The Role of Natriuretic Peptides (BNP and NT-proBNP) in Heart Failure
Katherine Soreng, PhD, Director, Clinical and Scientific Liaisons
Siemens Healthcare Diagnostics
The World Health Organization reports that cardiovascular disease is the number
one cause of death in the industrialized world. Of the deaths attributed to CVD,
an estimated 7.3 million were due to coronary heart disease, with another 6.2 million
deaths caused by stroke. Heart failure care constitutes an increasing economic burden
on the health care systems around the globe. While the lifetime costs of care of heart
failure may vary in different regions of the world, there is no question that the high costs
associated with heart failure significantly impact healthcare systems and economies.
Natriuretic peptides (NPs) are a useful test to distinguish patients with heart failure
from those without heart failure.
Webinars are complimentary and remain available online for 12 months after the
live webinar date. Log on and learn!
For additional information on natriuretic peptides, visit www.siemens.com/cardiacdisease